You are here

Sanofi

ASH: J&J, Sanofi square off in newly diagnosed multiple myeloma

Fierce Pharma

Wed, 12/13/23 - 09:45 am

Multiple Myeloma

FTC, in unusual move, leads Sanofi to terminate a drug research deal

BioPharma Dive

Tue, 12/12/23 - 10:43 pm

Maze Therapeutics

Kymera’s protein degrader starts Phase II trial in atopic dermatitis

Clinical Trials Arena

Fri, 12/8/23 - 11:05 am

protein degradation

clinical trials

atopic dermatitis

Sanofi’s Phase III multiple myeloma trial meets primary goal

Clinical Trials Arena

Fri, 12/8/23 - 11:02 am

cliincal trials

Multiple Myeloma

monoclonal antibodies

Dupixent for cancer? Researchers test blockbuster med as an immunotherapy-booster

Fierce Biotech

Thu, 12/7/23 - 11:13 pm

Sanofi CEO: Drugmaker has stocked pipeline but must win over investors

Medical Marketing and Media

Thu, 12/7/23 - 11:10 pm

Sanofi, facing skeptical investors, predicts $5B sales for 3 drugs, names 9 more blockbusters

Fierce Biotech

Thu, 12/7/23 - 10:19 am

Sanofi spins up AI pact, inking $140M deal to apply Aqemia’s physics algorithms to drug discovery

Fierce Biotech

Tue, 12/5/23 - 09:57 am

artificial intelligence

small molecule drugs

J&J, AbbVie, Sanofi and many other companies face competition probe in Turkey

Fierce Pharma

Sun, 12/3/23 - 09:36 pm

Sanofi, Regeneron eye Dupixent label expansion with promising COPD data

Medical Marketing and Media

Tue, 11/28/23 - 10:27 am

clinical trials

With filing in Sanofi and Mylan insulin lawsuit, FTC amps up scrutiny on pharma's patent tactics

Fierce Pharma

Tue, 11/21/23 - 10:54 pm

Senate Democrats press Sanofi and AZ for answers as 'unprecedented' demand spurs shortage of RSV antibody Beyfortus

Fierce Pharma

Mon, 11/20/23 - 09:38 pm

Can This Pharma CEO Change The Way Drugs Are Discovered, Developed, And Delivered With AI?

Forbes

Wed, 11/8/23 - 10:16 am

Sanofi pays $30M for first look at MeiraGTx's data and a shot to brew up deals

Fierce Biotech

Tue, 10/31/23 - 09:25 pm

drug development

Tricks and Treats as Biopharma’s Q3 Earnings Season Gets Underway

BioSpace

Sun, 10/29/23 - 08:53 pm

Bristol Myers Squibb

Sanofi loses $21 bln in market value after dropping 2025 profit target

Reuters

Sun, 10/29/23 - 08:51 pm

consumer health

Sanofi loses $21 bln in market value after dropping 2025 profit target

Reuters

Fri, 10/27/23 - 11:43 am

Sanofi reports setbacks to Denali, Kymab and Principia assets, delivering mix of misses and halts

Fierce Biotech

Fri, 10/27/23 - 11:36 am

Principia Biopharma

Sanofi reports positive data from Phase III trial of Dupixent

Clinical Trials Arena

Tue, 10/24/23 - 09:51 am

clinical trials

eosinophilic esophagitis

Dupixent returns as top Rx, OTC brand for September

Medical Marketing and Media

Tue, 10/17/23 - 09:41 pm

Pages